CA Stock MarketDetailed Quotes
EPRX Eupraxia Pharmaceuticals Inc
- 3.560
- -0.040-1.11%
15min DelayMarket Closed Aug 16 16:00 ET
126.82MMarket Cap-2798P/E (TTM)
3.690High3.510Low8.05KVolume3.510Open3.600Pre Close28.54KTurnover8.19052wk High0.03%Turnover Ratio35.62MShares3.25052wk Low-1.272EPS TTM106.42MFloat Cap9.100Historical HighLossP/E (Static)29.89MShs Float0.800Historical Low-1.551EPS LYR5.00%Amplitude--Dividend TTM6.23P/B1Lot Size--Div YieldTTM
Eupraxia Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 14.81%6.56M | 89.27%6.69M | 58.07%27.85M | 69.78%12.16M | 84.50%6.54M | 19.77%5.71M | 30.18%3.54M | 20.26%17.62M | 164.95%7.16M | -10.75%3.54M |
| Selling and administrative expenses | 34.36%2.58M | 99.55%2.52M | 82.67%7.28M | 21.38%1.78M | 192.23%2.01M | 109.43%1.92M | 12.01%1.26M | -42.79%3.99M | 18.59%1.47M | -40.47%689.34K |
| -General and administrative expense | 34.36%2.58M | 99.55%2.52M | 82.67%7.28M | 21.38%1.78M | 192.23%2.01M | 109.43%1.92M | 12.01%1.26M | -42.79%3.99M | 18.59%1.47M | -40.47%689.34K |
| Research and development costs | 4.88%3.97M | 83.57%4.18M | 50.87%20.56M | 80.92%10.49M | 59.22%4.48M | -0.63%3.79M | 45.95%2.27M | 79.55%13.63M | 303.95%5.8M | 1.03%2.82M |
| Depreciation amortization depletion | ---- | ---- | ---- | ---- | 0.65%36.71K | ---- | ---- | ---- | ---- | 57.38%36.48K |
| -Depreciation and amortization | ---- | ---- | ---- | ---- | 0.65%36.71K | ---- | ---- | ---- | ---- | 57.38%36.48K |
| Operating profit | -14.81%-6.56M | -89.27%-6.69M | -58.07%-27.85M | -69.78%-12.16M | -84.50%-6.54M | -19.77%-5.71M | -30.18%-3.54M | -20.26%-17.62M | -164.95%-7.16M | 10.75%-3.54M |
| Net non-operating interest income (expenses) | 179.85%119.38K | 34.00%-84.77K | 44.25%-307.2K | 183.38%103.08K | -16.46%-127.1K | 24.60%-149.5K | 46.42%-128.44K | 42.92%-551.06K | 48.33%-123.62K | 54.33%-109.14K |
| Non-operating interest income | 163.49%401.23K | 44.98%236.37K | 99.85%862.97K | 97.51%358.88K | 36.10%191.66K | 71.92%152.27K | 476.52%163.03K | 737.62%431.8K | 629.20%181.71K | 838.44%140.82K |
| Non-operating interest expense | -6.60%281.85K | 10.18%321.14K | 19.06%1.17M | -16.22%255.8K | 27.52%318.76K | 5.21%301.77K | 8.76%291.48K | -3.36%982.86K | 15.58%305.33K | -1.58%249.96K |
| Other net income (expenses) | 110.06%366.83K | 315.09%626.31K | 5.73%-775.15K | 207.35%1.24M | 738.31%1.85M | -4,073.10%-3.65M | -428.81%-291.19K | 69.71%-822.26K | -4,382.68%-1.15M | -258.84%-289.16K |
| Gain on sale of security | 109.76%355.46K | 315.19%626.31K | 5.56%-770.3K | 207.42%1.24M | 738.31%1.85M | -3,805.64%-3.64M | -428.56%-291.05K | 13.37%-815.62K | -4,507.65%-1.15M | -258.84%-289.16K |
| Special income (charges) | 351.50%11.37K | --0 | 26.99%-4.85K | 42.93%-290.7142 | --0 | 30.50%-4.52K | ---138 | ---6.64K | ---509.3877 | --0 |
| -Gain on sale of property,plant,equipment | 351.50%11.37K | --0 | 26.99%-4.85K | 42.93%-290.7142 | --0 | 30.50%-4.52K | ---138 | ---6.64K | ---509.3877 | --0 |
| Income before tax | 36.16%-6.07M | -55.51%-6.15M | -52.34%-28.93M | -28.20%-10.82M | -22.24%-4.82M | -95.06%-9.51M | -31.37%-3.96M | -3.61%-18.99M | -184.32%-8.44M | 2.11%-3.94M |
| Income tax | -5K | 5K | 36.42K | 0 | 0 | 0 | ||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 36.21%-6.06M | -55.63%-6.16M | -52.53%-28.97M | -28.63%-10.86M | -22.24%-4.82M | -95.06%-9.51M | -31.37%-3.96M | -3.61%-18.99M | -184.32%-8.44M | 2.11%-3.94M |
| Net income continuous operations | 36.21%-6.06M | -55.63%-6.16M | -52.53%-28.97M | -28.63%-10.86M | -22.24%-4.82M | -95.06%-9.51M | -31.37%-3.96M | -3.61%-18.99M | -184.32%-8.44M | 2.11%-3.94M |
| Noncontrolling interests | 56.19%-56.68K | -87.65%-113.9K | -48.70%-745.21K | -82.84%-384.68K | -69.29%-172.34K | 12.09%-129.38K | -10.20%-60.7K | -68.17%-501.14K | -351.41%-210.39K | 19.24%-101.8K |
| Net income attributable to the company | 35.94%-6.01M | -55.13%-6.04M | -52.63%-28.22M | -27.25%-10.47M | -21.00%-4.65M | -98.40%-9.38M | -31.77%-3.9M | -2.54%-18.49M | -181.65%-8.23M | 1.56%-3.84M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 35.94%-6.01M | -55.13%-6.04M | -52.63%-28.22M | -27.25%-10.47M | -21.00%-4.65M | -98.40%-9.38M | -31.77%-3.9M | -2.54%-18.49M | -181.65%-8.23M | 1.56%-3.84M |
| Diluted earnings per share | 60.47%-0.17 | -16.67%-0.21 | -21.88%-1.17 | 1.75%-0.3828 | -4.63%-0.1913 | -78.73%-0.43 | 13.57%-0.18 | 34.89%-0.96 | -98.21%-0.3896 | 33.38%-0.1828 |
| Basic earnings per share | 60.47%-0.17 | -16.67%-0.21 | -21.88%-1.17 | 1.75%-0.3828 | -4.63%-0.1913 | -78.73%-0.43 | 13.57%-0.18 | 34.89%-0.96 | -98.21%-0.3896 | 33.38%-0.1828 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg